title: Side effects of therapy: case 1. Nephrotic syndrome associated with gefitinib therapy.
authors.affiliation: The Secomd Department of Internal Medicine, Hirosaki University School of Medicine, Hirosaki-City, Aomori, Japan.
authors.forename: Ryuichiro
authors.initials: R
authors.lastname: Kumasaka
authors.forename: Norio
authors.initials: N
authors.lastname: Nakamura
authors.forename: Kenichi
authors.initials: K
authors.lastname: Shirato
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Osawa
authors.forename: Shingo
authors.initials: S
authors.lastname: Takanashi
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Hasegawa
authors.forename: Hideaki
authors.initials: H
authors.lastname: Yamabe
authors.forename: Masayuki
authors.initials: M
authors.lastname: Nakamura
authors.forename: Michiko
authors.initials: M
authors.lastname: Tamura
authors.forename: Ken
authors.initials: K
authors.lastname: Okumura
mesh_terms: D000368:Aged; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D018307:Neoplasms, Squamous Cell / Q000188:drug therapy; D009404:Nephrotic Syndrome / Q000139:chemically induced* / Q000473:pathology; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D011799:Quinazolines; D000077156:Gefitinib